In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity

Highlights • Immunizing efficacy of 52 pneumococcal proteins evaluated in a mouse challenge model. • Proteins were selected based on genetic conservation and surface accessibility to antibody. • Anti-sera used to investigate antigen expression across multiple serotypes. • Seven protective antigens w...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 34; no. 50; pp. 6292 - 6300
Main Authors Anderson, Richard J, Guru, Siradanahalli, Weeratna, Risini, Makinen, Shawn, Falconer, Derek J, Sheppard, Neil C, Lang, Susanne, Chang, Bingsheng, Goenaga, Anne-Laure, Green, Bruce A, Merson, James R, Gracheck, Stephen J, Eyles, Jim E
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 07.12.2016
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • Immunizing efficacy of 52 pneumococcal proteins evaluated in a mouse challenge model. • Proteins were selected based on genetic conservation and surface accessibility to antibody. • Anti-sera used to investigate antigen expression across multiple serotypes. • Seven protective antigens were evaluated in additional animal models. • Protective antigens were Histidine triad’s or proteins bearing LPXTG linkage domains.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2016.10.061